Contact Hours: 1.5

Max CEU Credits: 0.15

Learning Objectives:

On completion of the chapter, the reader will be able to
1. Identify major risk factors for the development of lung cancer.
2. Explain the pathologic progression of lung cancer and its relationship with signs and symptoms of the disease.
3. Make appropriate recommendations for screening or preventative measures in high-risk patients.
4. Understand staging of lung cancer patients and how it influences treatment decisions.
5. List the rationale, advantages, disadvantages, and place in therapy for adjuvant and neoadjuvant chemotherapy
6. Identify the chemotherapeutic regimens of choice for limited and extensive small cell lung carcinoma, as well as local, locally advanced, and advanced non–small cell lung carcinoma.
7. Monitor patients for chemotherapy-associated toxicity, and recommend appropriate management.
8. Distinguish the treatment goals of palliative care versus those of first-line treatment.

Faculty:

ACPE No:
014-999-07-102-H04

---

The University of Georgia College of Pharmacy in on probation as an accredited provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education. Next scheduled review for purposes of restoring accreditation or removing accredited provider status: June 2009